Eckhardt Sue Gail

CIK 00018237692 companiesALAMEDA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001823769

Recent Transactions

20 trades

Sale
EXELIXIS, INC.$EXEL
Common Stock
2026-02-13$43.79/sh−3,856→ 17,524 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2025-06-02$42.74/sh−18,834→ 21,384 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2025-06-02$43.67/sh−4→ 21,380 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2025-05-29+9,812→ 40,218 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2025-02-14$23.24/sh+7,712→ 41,974 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2025-02-14$35.01/sh−7,712→ 34,262 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2025-02-14−7,712→ 23,136 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2025-02-14$35.04/sh−3,856→ 30,406 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2024-06-05+6,000→ 6,000 total
Award
Syros Pharmaceuticals, Inc.
Common Stock
2024-06-05+4,000→ 16,000 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2024-05-31+18,838→ 34,262 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2024-01-05+15,424→ 15,424 total
Award
EXELIXIS, INC.$EXEL
Option (right to buy)
2024-01-05+30,848→ 30,848 total
Award
Syros Pharmaceuticals, Inc.
Common Stock
2023-06-01+4,000→ 12,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-01+6,000→ 6,000 total
Award
Syros Pharmaceuticals, Inc.
Common Stock
2022-09-16+8,000→ 8,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-09-16+12,000→ 12,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-06-01+17,500→ 17,500 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2021-06-08+17,500→ 17,500 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2020-09-08+35,000→ 35,000 total

Companies

Recent Filings

Address

C/O EXELIXIS, INC. 1851 HARBOR BAY PARKWAY

ALAMEDA, CA, 94502

View on SEC.gov